Skip to main content
Clinical Trials/NCT05415839
NCT05415839UnknownNot Applicable

Efficacy of Fractional CO2 Laser Versus Pulsed Dye Laser in the Treatment of Fingernail Psoriasis, a Randomized Controlled Trial.

Cairo University0 sites30 target enrollmentStarted: June 25, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Primary Endpoint
Nail psoriasis index (NAPSI)

Study Overview

Brief Summary

The aim of this work is to assess the efficacy and safety of fractional CO2 laser therapy in comparison to pulsed dye laser (PDL) in the treatment of nail psoriasis.

Detailed Description

Study Design:

Randomized Clinical Trial

  • Inclusion criteria:
  • All patients with bilateral nail psoriasis.
  • Age: Above 18
  • Sex: both sexes
  • Exclusion criteria:
  • Cases who received treatment (systemic or topical) in the last 3 months before inclusion.
  • Patients with proven onychomycosis by the microscopic mount of nail scraping
  • Patients with excessive manual work
  • Methodology in detail:
  • All patients will be given written informed consent to participate in this study, children's parents are to sign their consent.
  • Intra-patient randomization of 30 patients will be done so that the nails of each hand will be randomly included in one of two groups:
  1. Group A: The patient will receive 3 sessions of 1 month in-between of fractional CO2 laser with the following parameters: Two passes of 15 J, stacking 2, dwell time 500 Us, spacing 300 Um
  2. Group B: The patient will receive 3 sessions of pulsed dye laser of 1 month in-between with the following parameters: Two passes of 7 mm handpiece, 7.5 J, 0.5 msec pulse duration.
  • Assessment will be carried as follows:

  • Full medical history of the disease and associated DM, HTN, or other systemic diseases.

  • Nail scrapping will be don by 30% KOH solution to exclude onychomycosis.

  • Clinical assessment by nail psoriasis index (NAPSI) (11) before treatment, 1 month and 3 months after the last session.

  • Photography before treatment, before each session of laser together with 1 month after the last session, and after 3 months of follow-up, photos will be examined by 2 blinded investigators.

  • Onychoscopic assessment will be done before treatment and after 1 month of the last session together with after 3 months follow up.

  • Capillorscopy of the proximal nail fold will be done before treatment and after 1 month of the last session together with after 3 months follow up.

  • Nail psoriasis quality of life scale (NPQ10) (12). will be done at the first visit, 1 month after the last session together with after 3 months follow up.

  • Visual analog scale (VAS) will be used to assess the pain of laser sessions.

  • Patient satisfaction will be reported at the end of the study by patient satisfaction score (excellent, very good, good, bad, very bad).

  • Primary outcomes (Most important measurable outcomes)

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • - All patients with bilateral nail psoriasis.
  • Age: Above 18
  • Sex: both sexes

Exclusion Criteria

  • - Cases who received treatment (systemic or topical) in the last 3 months before inclusion.
  • Patients with proven onychomycosis by the microscopic mount of nail scraping
  • Patients with excessive manual work

Outcomes

Primary Outcomes

Nail psoriasis index (NAPSI)

Time Frame: change rom baseline at 3 months

Secondary Outcomes

  • diameter of vessels by dermoscopy(change from baseline at 3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hagar El Sayed

Dr

Cairo University

Similar Trials